180 Life Sciences Corp. Files 8-K/A Amendment
Ticker: FRMM · Form: 8-K/A · Filed: Jan 2, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K/A |
| Filed Date | Jan 2, 2025 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.0001, $1.68 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-action, filing
TL;DR
**180 Life Sciences Corp. filed an 8-K/A amendment, signaling major corporate changes.**
AI Summary
180 Life Sciences Corp. filed an amendment (8-K/A) on January 2, 2025, to a previous Form 8-K dated December 27, 2024. This amendment pertains to material modifications to security holder rights, changes in control, officer appointments, and other events. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates significant corporate actions and potential changes affecting the rights and control of 180 Life Sciences Corp.'s security holders.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings often signal significant corporate events that can introduce volatility and uncertainty for investors.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former company name
- 20250102 (date) — Filing date of the amendment
- 20241227 (date) — Original filing date
FAQ
What is the primary purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previous Form 8-K filed on December 27, 2024, addressing material modifications to security holder rights, changes in control, officer appointments, and other events.
When was this amendment filed with the SEC?
The amendment was filed on January 2, 2025.
What was 180 Life Sciences Corp. formerly known as?
180 Life Sciences Corp. was formerly known as KBL Merger Corp. IV.
In which state is 180 Life Sciences Corp. incorporated?
180 Life Sciences Corp. is incorporated in Delaware (DE).
What is the Standard Industrial Classification (SIC) code for 180 Life Sciences Corp.?
The SIC code for 180 Life Sciences Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 2,170 words · 9 min read · ~7 pages · Grade level 11.8 · Accepted 2025-01-02 16:30:07
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ATNF The NASDAQ Stock Mar
- $1.68 — f the Company with an exercise price of $1.68 per share and cashless exercise rights,
Filing Documents
- ea0226552-8ka1_180life.htm (8-K/A) — 88KB
- 0001213900-25-000398.txt ( ) — 312KB
- atnf-20241227.xsd (EX-101.SCH) — 4KB
- atnf-20241227_def.xml (EX-101.DEF) — 26KB
- atnf-20241227_lab.xml (EX-101.LAB) — 36KB
- atnf-20241227_pre.xml (EX-101.PRE) — 25KB
- ea0226552-8ka1_180life_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 180 LIFE SCIENCES CORP. Date: January 2, 2025 By: /s/ Blair Jordan Blair Jordan Interim Chief Executive Officer 6